In Treatment of Type 2 diabetes mellitus D Con 10mg Tablet works by increasing the amount of insulin your body produces (in the pancreas). The insulin then works to lower your blood glucose level. It is usually taken once a day. You should keep taking it for as long as it is prescribed Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
It is unsafe to consume alcohol with D Con 10mg Tablet.
D Con 10mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
D Con 10mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Monitor the breastfed baby’s blood sugar during treatment with D Con 10mg Tablet
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
D Con 10mg Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
D Con 10mg Tablet should be used with caution in patients with liver disease. Dose adjustment of D Con 10mg Tablet may be needed. Please consult your doctor. Use of D Con 10mg Tablet is not recommended in patients with severe liver disease. They can experience very low blood sugar levels while taking this medicine.
You should skip a dose of D Con 10mg Tablet if a meal is skipped, and add a dose of medicine if you eat an extra meal.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Johnlee Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)